Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome, leaky guts, and infection: Metabolic syndrome often accompanies obesity and hyperglycemia and is associated with a breakdown in the integrity of the intestinal barrier and increased risk of systemic infection. Thaiss et al. found that mice with systemic infection of a Salmonella analog, Citrobacter rodentium , also exhibited hyperglycemia. Deletion of the glucose transporter GLUT2 altered sensitivity to chemically induced epithelial permeability and protected mice from pathogen invasion. The authors also found a correlation in humans between glycated hemoglobin (an indicator of hyperglycemia) and serum levels of pathogen recognition receptor ligands. Science , this issue p. 1376
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thaiss et al. clearly showed that hyperglycemia drives intestinal permeability by the glucose transporter GLUT2-dependent transcriptional reprogramming of intestinal epithelial cells, resulting in changes in tight and adherence junction integrity, and a systemic influx of microbial products into portal blood [274].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [274]
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types
Jaitin, D. A., Kenigsberg, E., Keren-Shaul, H., Elefant, N., Paul, F., Zaretsky, I., Mildner, A., Cohen, N., Jung, S., Tanay, A., et al. (2014) · Science · doi:10.1126/science.1247651 · Cited by 1,795
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684
Cited by
Items 601–700 of 965
Non-O1/non-O139 Vibrio cholerae bacteremia and hepatitis in diabetic patient, France, winter 2019
Laurens, S., Wilhelm, N., Février, F., Coppin, D., Mothes, M., Quilici, M., & Metsu, D. (2024) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2024.116371 · Cited by 6
Wang, Y., Gao, J. Z., Gurung, P., Short, S. P., Xiong, Y., Canna, S., & Kang, Z. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01355-x · Cited by 7
“The animal experiments were approved by the Institutional Animal Care and Use Committee of the University of Iowa.”
A Systematic Review of Gastrointestinal Manifestations in Diabetic Nephropathy
Zheng, S., & Ma, J. (2019) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2019.00014 · Cited by 6
Longo, M., Jericó, D., Córdoba, K. M., Riezu‐Boj, J. I., Urtasun, R., Solares, I., Sampedro, A., Collantes, M., Peñuelas, I., Moreno-Aliaga, M. J., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511938 · Cited by 6
Carpio, L. E., Olivares, M., Benítez‐Páez, A., Serrano‐Candelas, E., Barigye, S. J., Sanz, Y., & Gozalbes, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115744 · Cited by 5
“Furthermore, mechanistic studies conducted on rodents have shown that hyperglycemia can increase intestinal barrier permeability through GLUT2-dependent transcriptional reprogramming of intestinal epithelial cells, which alters tight junction integrity, ultimately resulting in leaky mucosa [14].”
BackgroundKelso, A. L. (2024) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.556 · Cited by 7
A dietary source of antibiotic tolerance
Lundgren, P., Sharma, P. V., & Thaiss, C. A. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.07.013 · Cited by 6
Self-citationLiver microbes controlling immunity: Facts and pitfalls
Tilg, H., & Adolph, T. E. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.03.001 · Cited by 6
Chae, S. A., Son, J. S., de Avila, J. M., Du, ., & Zhu, M. J. (2022) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00128.2022 · Cited by 6
Yuan, H.-L., Zhang, X., Peng, D.-Z., Lin, G.-B., Li, H., Li, F., Lu, J.-J., & Chu, W. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s406884 · Cited by 6
“This causes the development of a serious bacterial infection.(26) The intestinal defecation function is impaired because of damage to the intestinal barrier function or bacterial infection.”
BackgroundCoagulation Signalling and Metabolic Disorders: Lessons Learned from Animal Models
Madhusudhan, T., & Ruf, W. (2019) · Hämostaseologie · doi:10.1055/s-0039-1688800 · Cited by 7
Stadlbauer, V. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13020220 · Cited by 6
“For example, a high-fat and high-glucose diet lead to increased gut permeability, translocation of bacterial products, a low grade inflammatory response, and insulin resistance, indicating that the gut-liver axis is involved in the metabolic sequelae of the western diet [6,7].”
BackgroundLi, Y., Xu, Q., Wang, J., Xin, Y., Zhang, Y., Qin, X., Xu, K., Yang, X., & Wang, X. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c07282 · Cited by 7
Jiang, Y. Z., Tang, Y., Liu, Z., Yang, X., Zhou, M.-Y., Liang, Y., Ding, J., & Liao, Y. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-02022-3 · Cited by 6
“Moreover, hyperglycemia alters epithelial cell function by interfering with N-glycan biosynthesis, which impairs cell– cell adhesion (Thaiss et al. 2018 ; Nita-Lazar et al. 2010).”
KAT5/8-mediated GPX4 lactylation facilitates ferroptosis and inflammation in diabetic retinopathy
Zhou, Y., & Du, M. (2026) · Experimental Cell Research · doi:10.1016/j.yexcr.2026.114915 · Cited by 5
Huang, S., Yu, S., Zhang, W., Qi, D., Pei, X., Lu, D., Ba, M., Xuan, S., Huang, D., Yang, J., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-09657-0 · Cited by 6
“Micewerefastedfor4 h and administered 150 μL FITC-dextran by oral gavage 82,83 .”
Bashiardes, S., Heinemann, M., Adlung, L., Valdés‐Mas, R., Mahdi, J. A., Nobs, S. P., Tuganbaev, T., Yamada, T., Horn, M., Mor, U., et al. (2026) · Nature Microbiology · doi:10.1038/s41564-025-02253-8 · Cited by 6
Self-citationGut microbiota and immunometabolism in obesity
Torres-Mayo, A., Liébana-García, R., Olivares, M., Pellón, A., Anguíta, J., & Sanz, Y. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2667610 · Cited by 5
“47 In particular, this process perturbs protein N-glycosylation by inducing a marked downregulation of genes critical for maintaining epithelial barrier function.”
Li, J., Liu, Y., Li, Y., Sun, T., Xiang, H., & He, Z. (2023) · Biomedicines · doi:10.3390/biomedicines12010054 · Cited by 5
“Mechanistic studies on rodents identified that hyperglycemia may increase intestinal barrier permeability and alter tight junction integrity through the GLUT2-dependent transcriptional reprogramming of intestinal epithelial cells [36].”
BackgroundJiang, Y., Wang, S., Shuai, J., Zhang, X., Zhang, S., Huang, H., Zhang, Q., & Fu, L. (2024) · Food & Function · doi:10.1039/d3fo05708a · Cited by 5
Optimized Magnetically Docked Ingestible Capsules for Non‐Invasive Refilling of Implantable Devices
Al‐Haddad, H., Guarnera, D., Tamadon, I., Arrico, L., Ballardini, G., Mariottini, F., Cucini, A., Ricciardi, S., Vistoli, F., Rotondo, M. I., et al. (2024) · Advanced Intelligent Systems · doi:10.1002/aisy.202400125 · Cited by 6
Wang, Y., Wang, X., Niu, X., Han, K., Ru, N., Xiang, J., & Linghu, E. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176881 · Cited by 6
Khizar, H., Hu, Y., Gu, W., Yang, J., Jin, H., He, X., Zhang, X., & Yang, J. (2024) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848241294002 · Cited by 5
“25 This study has certain limitations.”
Yang, J., Wu, Y. Z., Jiang, Z., Jiao, L., & Wang, Y. (2025) · Journal of Food Science · doi:10.1111/1750-3841.70015 · Cited by 7
Obesity and infl ammatory bowel disease: is there a link?
Равильевна, Б. Г., Livzan, M. A., & Shmurygina, E. A. (2020) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-182-10-133-141 · Cited by 5
Sodium nitroprusside protects HFD induced gut dysfunction via activating AMPKα/SIRT1 signaling
Li, X., Li, C., Li, Y., Liu, C., Liang, X., Liu, T., & Liu, Z. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01934-y · Cited by 6
“Background The gut dysfunction, which is characterized by gut microbiota dysbiosis and intestine epithelium barrier impairment, has a strong link to the development of metabolic disorders such as obesity and type 2 diabetes mellitus [1, 2].”
BackgroundIL-25 Treatment Improves Metabolic Syndrome in High-Fat Diet and Genetic Models of Obesity
Smith, A. D., Fan, A. X., Qin, B., Desai, N., Zhao, A., & Shea‐Donohue, T. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s335761 · Cited by 5
“IL-25 Effects on TEER in HFD-Induced and Genetic Obesity There is evidence that obesity and hyperglycemia are associated with increased intestinal permeability.(34,35) To determine if intestinal permeability was increased in the small intestine in diet-induced obesity and/or in”
BackgroundMa, K., Li, Y., Dong, X., & Guo, J. (2022) · European Journal of Inflammation · doi:10.1177/1721727x221106506 · Cited by 5
The Gut as a Potential Centerpiece in Fructose-Driven Dysmetabolism
Sellami, E., Anhê, G. F., Douard, V., & Anhê, F. F. (2023) · Current Molecular Biology Reports · doi:10.1007/s40610-023-00156-3 · Cited by 5
“…because in Zhang et al. fructose did not cause glucose intolerance [59], and given that hyperglycemia per se impairs gut barrier integrity [60], it remains to be established whether the effect of high-fructose diet on gut permeability is secondary to dysregulation of glucose homeostasis.”
Eraqi, W. A., El‐Sabbagh, W. A., Aziz, R. K., Elshahed, M. S., Youssef, N. H., & Elkenawy, N. M. (2024) · Animal Microbiome · doi:10.1186/s42523-024-00320-9 · Cited by 5
“Beside the sensitive role of PPAR-γ toward gut microbiome homeostasis, it has an anti-inflammatory activity in pancreatitis cases, which could develop after radiation exposure and carry a high incidence of diabetic risk and intestinal barrier dysfunction [4, 5, 31, 77, 78].”
BackgroundVilla-Rodríguez, J. A., Kerimi, A., Tumova, S., & Williamson, G. (2019) · Food & Function · doi:10.1039/c9fo00810a · Cited by 6
Multiomics Profiling Reveals Signatures of Dysmetabolism in Urban Populations in Central India
Monaghan, T. M., Biswas, R., Nashine, R. R., Joshi, S. S., Mullish, B. H., Seekatz, A. M., Blanco, J. M., McDonald, J. A. K., Marchesi, J. R., Yau, T. O., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9071485 · Cited by 5
“A recent study suggested that this increased risk may be due to hyperglycaemia, either genetically, chemically or diet-induced, rather than obesity itself, which provides the mechanistic basis for intestinal barrier dysfunction [14].”
BackgroundGuo, Y., Liu, T., Li, W., Zhang, W., Cai, C., Lu, C., Gao, P., Cao, G., Li, B., Guo, X., et al. (2022) · Animals · doi:10.3390/ani12202740 · Cited by 5
“Inflammatory cytokines play an important role in intestinal mucosal immunity [38,39], and their dynamic regulation may develop inflammation [40].”
BackgroundHuang, X., Lei, L., Feng, F., & Shao, Y. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-05235-4 · Cited by 5
“Gut microbiota dysbiosis, characterized by an imbalance in the composition and activity of gut microbial communities, has been recently suggested to be involved in intestinal barrier dysfunction, and contributed to the establishment of metabolic diseases such as obesity [4], type 2 diabetes (T2D) [5], inflammatory bow…”
BackgroundSpecial Issue on the “Regulation and Physiopathology of the Gut Barrier”
Thenet, S., & Carrière, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810638 · Cited by 5
Diabetes compromises tight junction protein claudin 14 in the urinary bladder
Mohanty, S., White, J. K., Scheffschick, A., Fischer, B., Pathak, A. K., Tovi, J., Östenson, C., Aspenström, P., Brauner, H., & Brauner, A. (2024) · Cell and Tissue Research · doi:10.1007/s00441-024-03908-4 · Cited by 4
“Our observation in diabetic, db/db, mice is of importance in the context of UTI as these mice are known for compromised intestinal barrier with higher risk of enteric infection (Thaiss et al. 2018).”
BackgroundRuathong, W., Khuituan, P., Peerakietkhajorn, S., Teanpaisan, R., & Nopparat, J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0313395 · Cited by 4
Vito, F. D., Marasco, R., Suraci, E., Facciolo, A., Hribal, M. L., Sesti, G., Andreozzi, F., Luzza, F., & Fiorentino, T. V. (2025) · Diabetes · doi:10.2337/db25-0035 · Cited by 6
Dietary sugar intake, genetic susceptibility, and risk of dementia: A prospective cohort study
An, Y., Cao, L., Zheng, G., Liu, Y., Yang, H., Chen, L., Zhao, Y., Zhang, X., & Xia, Y. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100312 · Cited by 5
Bhatwa, A., Lau, T. C., McPhee, J. B., Anhê, F. F., Anhê, G. F., Fang, H., Barra, N. G., Li, Y. E., Duggan, B. M., Chan, D. Y., et al. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00251.2025 · Cited by 5
Zhao, X., Zheng, B., Ao, T., Xie, J., Chen, Y., El-Seedi, H. R., Huang, H., Liu, B., & Yu, Q. (2025) · Food Frontiers · doi:10.1002/fft2.70105 · Cited by 4
Fan, S., Zhang, C., Sun, P., Shi, H., Tian, Y., Ye, A., He, J., Wu, Y., Zhang, Q., & Fu, L. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.173369 · Cited by 4
Zhu, R., Li, L., Zhao, M., Zhang, B., Zhang, Z., Li, M., Yu, L., Song, Z., & Gu, N. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c16173 · Cited by 5
Food-derived extracellular vesicles: novel dietary regulators for metabolic homeostasis
He, Y., Yu, Z., Zhang, W., Nie, X., & Xie, J. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.108712 · Cited by 5
Liang, X., Zhang, Y., Xie, W., Xiong, J., Lin, S., Wen, Y., Cao, Y., Yu, S., Wang, K., Deng, J., et al. (2026) · Nature Microbiology · doi:10.1038/s41564-026-02381-9 · Cited by 4
Dimba, N. R., Mzimela, N., & Khathi, A. (2024) · Biomedicines · doi:10.3390/biomedicines12061275 · Cited by 6
“The current literature indicates that high-calorie diets impact the intestinal mucosal barrier, enterocytes, and overall intestinal permeability, leading to intestinal leakage in type 2 diabetes (T2D) patients [10].”
BackgroundInfluentialAbe, K., Takeda, M., Ishiyama, A., Shimizu, M., Goto, H., Iida, H., Fujimoto, T., Ueda‐Abe, E., Yamada, S., Fujiwara, K., et al. (2024) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2024.161900 · Cited by 4
Type III Secretion System in Intestinal Pathogens and Metabolic Diseases
Zhou, L., Zhang, Y., Wu, S., Kuang, Y., Jiang, P., Zhu, X., & Yin, K. (2024) · Journal of Diabetes Research · doi:10.1155/2024/4864639 · Cited by 4
Liang, J., Lin, X., Liao, X., Chen, X., Zhou, Y. Q., Zhang, L., Qin, Y., Meng, H., & Feng, Z. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1533984 · Cited by 5
Aboulalazm, F. A., Kazen, A. B., DeLeon, O., Müller, S., Saravia, F. L., Lozada-Fernández, V. V., Hadiono, M. A., Keyes, R. F., Smith, B. C., Kellogg, S. L., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2477819 · Cited by 5
Acetate Administration Ameliorates Streptozotocin‐Induced Hyperglycemia and Adipose Tissue Loss
Zhang, C., Wang, Z., Luo, L., Liu, X., Jia, Z., & Zhang, Y. (2025) · The FASEB Journal · doi:10.1096/fj.202500776r · Cited by 6
Zhang, D., Sun, X., Wang, H., & Chen, L. (2025) · Foods · doi:10.3390/foods14223871 · Cited by 4
“This deterioration can facilitate increased absorption of pathogens and toxins within the intestinal lumen, subsequently leading to intestinal inflammation and exacerbation of hyperglycemia [49,50].”
2019 Gut Microbiota for Health World Summit
Fuhler, G. M., Hecht, G. A., Foley, S. E., Cruz-Lebrón, A., & Hazleton, K. Z. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.08.044 · Cited by 5
Dutton, J. S., Hinman, S. S., Kim, R., Attayek, P. J., Maurer, M. A., Sims, C. E., & Allbritton, N. L. (2021) · Integrative Biology · doi:10.1093/intbio/zyab008 · Cited by 4
Bacteriological profile of the nasopharynx in patients with type 2 diabetes
Mizgała-Izworska, E., Żywiec, J., Klekotka, R., & Lukas, W. (2023) · Annals of Agricultural and Environmental Medicine · doi:10.26444/aaem/158024 · Cited by 4
Microbiota and Glucidic Metabolism: A Link with Multiple Aspects and Perspectives
Ciarambino, T., Crispino, P., Leto, G., Minervini, G., Para, O., & Giordano, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210409 · Cited by 5
Fenofibrate reduces glucose-induced barrier dysfunction in feline enteroids
Crawford, C. K., Beltran, A., Castillo, D., Matloob, M. S., Uehara, M. E., Quilici, M. L., Cervantes, V. L., & Kol, A. (2023) · Scientific Reports · doi:10.1038/s41598-023-49874-9 · Cited by 5
Hernández-Martín, M., Bocanegra, A., Garcimartín, A., Issa, J. Á., Redondo‐Castillejo, R., Macho‐González, A., Benedí, J., Sánchez-Muniz, F. J., & López‐Oliva, M. E. (2024) · Methods in cell biology · doi:10.1016/bs.mcb.2024.02.010 · Cited by 4
Modeling diabetic intestinal organoids: Aspects of rapid gut barrier disruption
Hahn, S., Han, I. W., Shin, S. H., Kim, G., & Kim, J. H. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151730 · Cited by 4
Li, G., Cheong, K., He, Y., Liew, A., Huang, J., Huang, C., Zhong, S., & Sathuvan, M. (2025) · Foods · doi:10.3390/foods14152708 · Cited by 4
“These microbial metabolites may further trigger immune stimulation and circulatory disorders, thereby exacerbating the risk of obesity and related metabolic disorders [12].”
Eran Elinav: Beyond the microbiome
Houston, S. A. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20181961 · Cited by 4
“We study many aspects of host–microbiome interactions and their potential involvement in human disease processes (Levy et al., 2015; Zeevi et al., 2015; Thaiss et al., 2016, 2018; Suez et al., 2018; Zmora et al., 2018).”
BackgroundSmall Bowel—Key Player in Health and Disease
Marlicz, W. M., & Koulaouzidis, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101748 · Cited by 4
“reported that hyperglycemia leads to disruption of the intestinal barrier followed by intestinal inflammation and systemic infection [6].”
BackgroundHankir, M. K., Seyfried, F., Schellinger, I. N., Schlegel, N., & Arora, T. (2021) · Metabolites · doi:10.3390/metabo11030153 · Cited by 4
“If this is similarly the case across species, it could also potentially explain the barrier-disruptive effects of ileal content from RYGB-treated compared with sham-operated rats on Caco-2 cells through increased glucose metabolism [25].”
BackgroundNutritional Regulation of Aging and Longevity
Moskalev, A. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-83017-5_21 · Cited by 5
Deng, P., Zhou, Y., Wang, X., Tang, K., Jiang, H., He, W., Zheng, H. X., Zhao, L., Gao, H., & Li, C. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00519 · Cited by 4
Hoffmanová, I., Sánchez, D., Szczepanková, A., Hábová, V., & Tlaskalová‐Hogenová, H. (2022) · Physiological Research · doi:10.33549/physiolres.934874 · Cited by 4
Advanced omics techniques shed light on CD1d-mediated lipid antigen presentation to iNKT cells
Morris, I., Croes, C.-A., Boes, M. L., & Kalkhoven, E. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159292 · Cited by 5
Ashaolu, J. O., Some, S. Y. M., Otuechere, C. A., Bamigboye, O. C., & Ashaolu, T. J. (2024) · Discover Public Health · doi:10.1186/s12982-024-00138-5 · Cited by 4
“In human models, a study by Thaiss et al. [69] showed that glycemia, inflammation, and intestinal permeability and HbA1c were positively associated with an elevated level of serum receptor pathogen recognition ligands by generating intestinal hyperglycemia.”
Hyperglycemia and periodontitis: Possible mechanisms of interaction
Buduneli, N. (2018) · Oral Diseases · doi:10.1111/odi.12970 · Cited by 4
Implications of microbe-mediated crosstalk in the gut: Impact on metabolic diseases
Beg, R., Gonzalez, K., & Martinez, K. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159180 · Cited by 4
Wang, Y., Wang, S., Xu, H., & Liu, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.939703 · Cited by 4
“Surprisingly, although IBD was associated with these two diseases, it was hyperglycemia, the most significant symptom of T2D, that independently drove IBD (3).”
BackgroundYang, J., & Li, S. (2024) · Journal of Biomaterials Applications · doi:10.1177/08853282241267253 · Cited by 3
“8 This, in turn, contributes to challenges in vascular regeneration and slows down the wound closure rate in diabetic patients.”
Yang, S.-M., Zhang, X.-D., Ma, H.-X., Wu, D., Liu, X., Yu, H., Li, S., Gao, W.-J., Liu, W.-W., & Li, S. (2023) · journal of nutritional oncology · doi:10.1097/jn9.0000000000000011 · Cited by 3
“[21] Malnutrition is prevalent among cancer patients, and the gut barrier function is impaired in malnourished patients, implying that the poor nutritional status may facilitate GDI and sepsis in cancer patients.”
BackgroundUnraveling the Role of Metabolic Endotoxemia in Accelerating Breast Tumor Progression
Nahmias, D., Maimon, O., Hermano, E., Drai, E., Chen, O., Popovtzer, A., Peretz, T., Meirovitz, A., & Elkin, M. (2025) · Biomedicines · doi:10.3390/biomedicines13081868 · Cited by 3
“Indeed, elevated plasma LPS concentrations (i.e., ME) were documented in obese patients and in animal models of obesity [8,11–15 , 17].”
Wen, D., Wang, X. G., He, Y., Hao, X., Huang, W., Zhou, H., Zhang, W., & Li, X. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104379 · Cited by 5
Intricate interplay between ORMDL3, ER stress, and autophagy in the diabetic intestine
Maličević, U., Rai, V., Škrbić, R., & Agrawal, D. K. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05424-7 · Cited by 9
“Beyond its metabolic effects, T2D is characterized by chronic hyperglycemia, which contributes to intestinal barrier dysfunction [ 11 ], thereby increasing susceptibility to IBD.”
Visvanathan, R., Houghton, M. J., Barber, E., Day, K., Kellow, N. J., & Williamson, G. (2025) · Scientific Reports · doi:10.1038/s41598-025-22312-8 · Cited by 3
“Supporting this idea, studies in mice have shown that intestinal GLUT2 knockdown can help preserve gut barrier function, reduce susceptibility to infection, modulate gut microbiota composition, and dampen systemic inflammation 42,43 .”
Faggin, S., Cerantola, S., Bosi, A., Giaroni, C., Napoli, E., Savarino, E. V., Contran, M., Porzionato, A., Pellegrini, C., Antonioli, L., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110710 · Cited by 3
“Enhanced permeability facilitates the translocation of bacterial endotoxins, driving low-grade inflammation and metabolic dysfunction [11].”
Baek, K., Yun, K., He, M. T., Kim, N. K., Kim, J., Ahn, K., & Kim, J. H. (2025) · Genes & Genomics · doi:10.1007/s13258-025-01707-x · Cited by 3
“…level, tight junction proteins such as occludin, claudins, and zonula occludens-1 (ZO-1) are essential for maintaining barrier integrity, and their downregulation has been directly linked to obesity progression and diabetes-associated com - plications (Al-Sadi et al. 2011; Thaiss et al. 2018).”
Mak, K. M., Ding, S. Y., & Jain, C. L. (2025) · The Anatomical Record · doi:10.1002/ar.70084 · Cited by 5
“Hyperglycemia is a recognized risk factor in the pathogenesis of diabetes and has also been shown to disrupt the gut barrier function (Thaiss et al., 2018).”
Jiang, Y. Z., Zhou, M.-Y., Zhang, J., Liang, Y., Ding, J., Liao, W., & Liao, Y. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05388-1 · Cited by 3
“Additionally, intestinal barrier dysfunction—a common feature of DR—leads to the translocation of pathogenic products due to “leaky gut,” which drives chronic retinal inflammation [37–39].”
Ultra-processed foods in inflammatory bowel disease: an emerging global health challenge
Vanderstappen, J., Hoekx, S., Vissers, E., Wellens, J., & Sabino, J. (2025) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2025.102072 · Cited by 3
Zhang, S., Chen, Y., Aa, N., Chen, X., Xie, T., Wang, Y., Cheng, T., Wang, M., Yu, H., Ji, X., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.12.007 · Cited by 4
Roles of zinc in the gut-liver axis
Grüngreiff, K., Reinhold, D., & Maret, W. (2026) · Annals of Hepatology · doi:10.1016/j.aohep.2026.102188 · Cited by 6
Cardiometabolic and metabolic profiles in irritable bowel syndrome associated with type 2 diabetes
Schmelter, F., Nowak, L., Beier, P., Tetzlaff-Lelleck, V., Kordowski, A., Föh, B., Witt, O., Schröder, T., Günther, U. L., Laumonnier, Y., et al. (2026) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00489.2025 · Cited by 3
Ma, Z., Shi, H., Bai, X., Wang, Z. P., Cao, J., Dong, Y., & Chen, Y. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2667735 · Cited by 3
“71,72 This metabolic cascade disrupts nutrient partitioning through two primary routes: unabsorbed dietary glucose spills into the distal intestine, and compromised tight junctions allow glucose-rich interstitial fluid to leak into the lumen.”
何曉碩, 郭战利, & Chen, Q. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10067-0 · Cited by 4
Dallali, H., Boukhalfa, W., Kheriji, N., Fassatoui, M., Jmel, H., Hechmi, M., Gouiza, I., Gharbi, M., Kammoun, W., Mrad, M., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1293124 · Cited by 3
Işıldar, B., Beydogan, A. B., Koyuturk, E., Coşkun, Z. M., Koyutürk, M., & Bolkent, S. (2024) · Histochemistry and Cell Biology · doi:10.1007/s00418-024-02311-y · Cited by 3
“So, understanding the connection between high fructose intake and intestinal system dysfunctions is essential, as the intestine is the primary absorption site (Thaiss et al. 2018).”
BackgroundDiabetes-induced depression: unravelling the role of gut dysbiosis
Sharma, V. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01643-3 · Cited by 3
“This endotoxemia triggers systemic inflammation and microbial shifts favoring pro-inflammatory taxa like Proteobacteria over beneficial com - mensals [46, 47].”
Govindasamy, C., Sikkandar, S., Al‐Numair, K. S., Alsaif, M. A., & Loganathan, C. (2025) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2025.2507817 · Cited by 3
“Hyperglycemia mediates intestinal barrier disruption, which consequently leads to the influx of microbes and microbial products, thereby causing enteric as well as systemic infections (Thaiss et al., 2018).”
Comorbidity Burden and Effectiveness of Immunotherapy in Metastatic Renal Cell Carcinoma
Yekedüz, E., Zarbá, M., Saad, E., Chehade, R. E. H., Eid, M., Saliby, R. M., Steiner, C., Machaalani, M., Nawfal, R., Semaan, K., et al. (2025) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2025.102385 · Cited by 3
High humidity environment increases FBG by impairing the intestinal barrier
Wang, Y., Zhuang, K., Yi, Q., Wu, Y., Luo, Y., Ouyang, Y., Liang, L., Li, C., & Luo, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1625609 · Cited by 3
A Carbohydrate Beverage Reduces Monocytes Expressing TLR4 in Children with Overweight or Obesity
Niemiro, G. M., Chiarlitti, N. A., Khan, N. A., & Lisio, M. D. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz294 · Cited by 4
Houghton, C. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820593-8.00014-8 · Cited by 4
Hu, S., Kou, Y., Liu, X., Rong, W., Han, H., & Zhang, G. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023137 · Cited by 5
“Emerging evidence indicates that T1D-induced hyperglycemia results in the disruption of the intestinal barrier and risk of enteric infection through reprogramming epithelial cells [2].”
BackgroundInfluentialPiccolo, B. D., Graham, J. L., Tabor‐Simecka, L., Randolph, C. E., Moody, B., Robeson, M. S., Kang, P., Fox, R., Lan, R. S.-L., Pack, L., et al. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003813 · Cited by 3
Role and molecular mechanism of NOD2 in chronic non-communicable diseases
Kong, L., Cao, Y., He, Y., & Zhang, Y. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-024-02451-7 · Cited by 5
“Moreover, diabetes increases circulating microbial products due to disrupting the imbalance of the gut microbiome and improving intestinal permeability [80, 81].”
Liu, Y., Ni-Ni, J., Long, W., Zou, X., Shuai, W., Meng-Jun, P., Li, X., & Xiao-Qin, C. (2024) · Fitoterapia · doi:10.1016/j.fitote.2024.106129 · Cited by 3
Wang, Y., Liang, Y., Huang, Y., wang, W., Long, X., Li, J., Cheng, T., Du, J., & Luo, X. (2024) · Poultry Science · doi:10.1016/j.psj.2024.104605 · Cited by 3
Metadata
- Authors
- Thaiss, C. A., Levy, M., Grosheva, I., Zheng, D., Soffer, E., Blacher, E., Braverman, S., Tengeler, A. C., Barak, O., Elazar, M., Ben-Zeev, R., Lehavi-Regev, D., Katz, M. N., Pevsner-Fischer, M., Gertler, A., Halpern, Z., Harmelin, A., Aamar, S., Serradas, P., Grosfeld, A., Shapiro, H., Geiger, B., & Elinav, E.
- Affiliations
- Weizmann Institute of Science (IL)
- Hebrew University of Jerusalem (IL)
- Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
- Tel Aviv Sourasky Medical Center (IL)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Elinav, Eran
- ORCID
- Venue
- Science
- Published
- 2018-03-23
- Volume
- 359
- Issue
- 6382
- Pages
- 1376-1383
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2794419196
- Cited by
- 942
- References
- 56
- Citations by year
- 2026: 91 · 2025: 134 · 2024: 129 · 2023: 102 · 2022: 142 · 2021: 126 · 2020: 102 · 2019: 74 · 2018: 38
- FWCI
- 30.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Science (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Bill & Melinda Gates Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- hyperglycemia, intestinal barrier dysfunction, gastrointestinal infections, obesity, diabetes mellitus, GLUT2, intestinal epithelial cells, tight junctions, adherens junctions, intestinal permeability, microbial translocation, HbA1c, glycemic control, gut microbiota, systemic inflammation
- MeSH terms
- Gastrointestinal Microbiome, Animals, Blood Glucose, Diabetes Mellitus, Experimental, Escherichia coli Infections, Glucose, Humans, Hyperglycemia, Intestinal Diseases, Intestinal Mucosa, Mice, Inbred Strains, Obesity, Permeability, Streptozocin, Gene Deletion, Caco-2 Cells, Citrobacter rodentium, Glucose Transporter Type 2, Mice, Enteropathogenic Escherichia coli, Receptors, Leptin, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.